Selskabsmeddelelse nr.: 16 Blue Vision A/S’ har i henhold til markedsmisbrugsforordningens art. 19 (forordning (EU) nr. 596/2014) modtaget vedhæftede indberetninger fra bestyrelsesmedlemmer og ledende medarbejdere og disses nærtståendes transaktioner med Blue Vision A/S’ aktier. Med venlig hilsen Blue Vision A/S Bestyrelsen Related posts: MPV annonce les résultats de son assemblée annuelle des actionnaires et la nomination […]
Category Archives: Public Companies
Stein Mart Enhances Loyalty Program Benefits
JACKSONVILLE, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) — Stein Mart (NASDAQ: SMRT) announced today it has enhanced its loyalty program to provide even more value for customers. Stein Mart has doubled the earn rate, which means cardholders now earn rewards twice as fast. Under the new program, called “SMart Rewards”, Stein Mart credit cardholders now […]
Primoris Services Corporation Announces Heavy Civil Award Valued Over $79 Million
DALLAS, Oct. 01, 2019 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two new heavy civil awards with a combined value over $79 million. The contracts were secured by Primoris Heavy Civil, part of the Civil segment. These awards were signed in the third quarter of 2019. The […]
Minerva Neurosciences Announces Update for Three Clinical Trials
WALTHAM, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced an update on three clinical-stage programs with roluperidone (MIN-101), seltorexant (MIN-202) and MIN-117. The Company will hold a conference call at 8:30 a.m. […]
AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, and Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for […]
Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, presented updated clinical data on the felezonexor (SL-801) Phase 1 trial in patients with advanced solid tumors at the European Society of Medical Oncology (ESMO) 2019 Annual Congress […]
VR Delineates 2×2 km Gold-Silver Geochemical Anomaly at Big Ten in Nevada, Stakes Additional Claims and Plans Follow-Up Geophysics
Figure 1 Gold geochemistry anomaly at Amsel, plotted on potassium airborne radiometric anomaly from a regional survey completed by VR in 2018. Gold in regolith soil samples is up to 0.25 g/t. Silver is anomalous over the same 1.8 x 2.2 km area, as are the epithermal trace element indicators arsenic and antimony; silver in […]
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) […]
Intrinsyc Announces New Orders Valued at $1,263,000
VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) — Intrinsyc Technologies Corporation (TSX: ITC and OTCQX: ISYRF) (“Intrinsyc” or the “Company”), a leading provider of solutions for the development of embedded and Internet of Things (“IoT”) products, today announced the receipt of orders from multiple clients, that in aggregate are valued at US$1,263,000. These orders […]
Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference
LEXINGTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced upcoming oral and poster presentations on MRT5005, an inhaled mRNA therapeutic, at the 33rd Annual North American […]